Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2014-001401-41Phase 4Active
Phase 4, randomised trial of tobramycin in cystic fibrosis (CF) and Pseudomonal infection (2 arms). Primary endpoint: Change in FEF75 (Z-score and L/s). Started May 2014; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2014-001401-41.